Neurosciences

Home / Specialties / Neuroscience

Minimally invasive technologies for new therapeutic perspectives in the neurological field

Gada Italia’s Neuroscience Business Unit was created with the aim of supporting hospitals and healthcare professionals in managing neurological disorders through the introduction of advanced, minimally invasive therapeutic solutions focused on patient wellbeing.

We work alongside clinical centers to make innovative technologies accessible, opening new perspectives in the treatment of complex neurological disorders.

Our commitment is to support physicians in their daily practice by providing not only state-of-the-art technological tools, but also training, consultancy, and continuous service designed to ensure the effectiveness, safety, and sustainability of the therapeutic pathway.

We strongly believe in an integrated model, in which the adoption of new technologies is accompanied by active and competent support: from the clinical evaluation phase to implementation in the operating room, and through to post-treatment monitoring. In this context, our Business Unit positions itself as a strategic partner for healthcare facilities wishing to expand their therapeutic offering in the neurological field, enhancing a multidisciplinary approach and always placing the patient at the center.

With a forward-looking vision, we continue to invest in the implementation of solutions that improve access to care, reduce intervention invasiveness, and contribute to the evolution of neurological medicine toward increasingly higher standards of quality and humanization.

1

Minimally invasive, high-precision therapies

2

Full support for healthcare facilities

3

Continuous technological innovation

4

Integrated and multidisciplinary approach

5

Improvement in patient quality of life

Discover in detail our solutions for every area of neuroscience.

/ product lines

Discover our product lines

Gada Italia’s Neuroscience Business Unit is dedicated to introducing cutting-edge technological solutions for the minimally invasive treatment of neurological disorders: the technologies offered in this field, using magnetic resonance-guided focused ultrasound (MRgFUS), are capable of treating selected neurological pathologies without the need for surgical incisions.

Neurological disorders, such as essential tremor and Parkinson’s disease, can have a significant impact on patients’ quality of life. Traditionally, therapeutic options included medications or invasive surgical procedures. However, not all patients respond adequately to medication, and surgical procedures involve risks and prolonged recovery times.

In this scenario, the solution offered by Gada Italia is the Exablate 4000 by Insightec —an innovative and less invasive therapeutic alternative.

The Exablate 4000 is designed to perform precise ablations of brain tissue through the combined use of focused ultrasound and magnetic resonance imaging. This technology allows physicians to visualize the treatment area in real time and monitor tissue temperature, ensuring a safe and effective intervention. Treatment is typically performed in a single session and does not require incisions, significantly reducing the risks associated with traditional surgical procedures.

The Exablate 4000 by Insightec represents an advanced technological solution that meets current clinical needs, offering patients safer and more effective therapeutic options for the management of neurological disorders.

Gada Italia’s Neuroscience Business Unit is dedicated to introducing cutting-edge technological solutions for the minimally invasive treatment of neurological disorders: the technologies offered in this field, using magnetic resonance-guided focused ultrasound (MRgFUS), are capable of treating selected neurological pathologies without the need for surgical incisions.

Neurological disorders, such as essential tremor and Parkinson’s disease, can have a significant impact on patients’ quality of life. Traditionally, therapeutic options included medications or invasive surgical procedures. However, not all patients respond adequately to medication, and surgical procedures involve risks and prolonged recovery times.

In this scenario, the solution offered by Gada Italia is the Exablate 4000 by Insightec —an innovative and less invasive therapeutic alternative.

The Exablate 4000 is designed to perform precise ablations of brain tissue through the combined use of focused ultrasound and magnetic resonance imaging. This technology allows physicians to visualize the treatment area in real time and monitor tissue temperature, ensuring a safe and effective intervention. Treatment is typically performed in a single session and does not require incisions, significantly reducing the risks associated with traditional surgical procedures.

The Exablate 4000 by Insightec represents an advanced technological solution that meets current clinical needs, offering patients safer and more effective therapeutic options for the management of neurological disorders.